Broad spectrum antiviral agent niclosamide and its therapeutic potential

J Xu, PY Shi, H Li, J Zhou - ACS infectious diseases, 2020 - ACS Publications
The recent outbreak of coronavirus disease 2019 (COVID-19) highlights an urgent need for
therapeutics. Through a series of drug repurposing screening campaigns, niclosamide, an …

Application of mesoporous silica nanoparticles in cancer therapy and delivery of repurposed anthelmintics for cancer therapy

M Koohi Moftakhari Esfahani, SE Alavi, PJ Cabot… - Pharmaceutics, 2022 - mdpi.com
This review focuses on the biomedical application of mesoporous silica nanoparticles
(MSNs), mainly focusing on the therapeutic application of MSNs for cancer treatment and …

Drug repurposing for cancer therapy

Y Xia, M Sun, H Huang, WL Jin - Signal Transduction and Targeted …, 2024 - nature.com
Cancer, a complex and multifactorial disease, presents a significant challenge to global
health. Despite significant advances in surgical, radiotherapeutic and immunological …

Comprehensive review on current interventions, diagnostics, and nanotechnology perspectives against SARS-CoV-2

DS Chauhan, R Prasad, R Srivastava… - Bioconjugate …, 2020 - ACS Publications
The coronavirus disease 2019 (COVID-19) has dramatically challenged the healthcare
system of almost all countries. The authorities are struggling to minimize the mortality along …

Repurposing old drugs to fight multidrug resistant cancers

J Dinić, T Efferth, AT García-Sosa, J Grahovac… - Drug Resistance …, 2020 - Elsevier
Overcoming multidrug resistance represents a major challenge for cancer treatment. In the
search for new chemotherapeutics to treat malignant diseases, drug repurposing gained a …

Quality by design steered development of Niclosamide loaded liposomal thermogel for Melanoma: In vitro and Ex vivo evaluation

S Shah, P Famta, V Fernandes, D Bagasariya… - European Journal of …, 2022 - Elsevier
Melanoma is the most malignant form of skin cancer across the globe. Conventional
therapies are currently ineffective which could be attributed to the rampant chemo …

Direct cyclodextrin-based powder extrusion 3D printing for one-step production of the BCS class II model drug niclosamide

M Pistone, GF Racaniello, I Arduino… - Drug Delivery and …, 2022 - Springer
Niclosamide (NCS) is a drug that has been used as an anthelmintic and anti-parasitic drug
for about 40 years. Recently, some studies have highlighted its potential in treating various …

Niclosamide inhalation powder made by thin-film freezing: Multi-dose tolerability and exposure in rats and pharmacokinetics in hamsters

MO Jara, ZN Warnken, S Sahakijpijarn, C Moon… - International journal of …, 2021 - Elsevier
In this work, we have developed and tested a dry powder form of niclosamide made by thin-
film freezing (TFF) and administered it by inhalation to rats and hamsters to gather data …

[HTML][HTML] Anthelmintics for drug repurposing: Opportunities and challenges

SE Alavi, HE Shahmabadi - Saudi Pharmaceutical Journal, 2021 - Elsevier
Drug repositioning is defined as a process to identify a new application for drugs. This
approach is critical as it takes advantage of well-known pharmacokinetics …

Drug repurposing in rare diseases: Myths and reality

C Fetro, D Scherman - Therapies, 2020 - Elsevier
While nearly 8000 rare diseases have been identified, only 5 percent have licensed
treatments. As most of these diseases are life threatening, it underscores the urgent need for …